Albert Einstein College of Medicine
Jack and Pearl Resnick Campus
1300 Morris Park Avenue
223 articles with Albert Einstein College of Medicine
Biohaven Pharma's NDA for its nasal spray zavegepant was accepted by the FDA, while Phase III results for its drug troriluzole to treat spinocerebellar ataxia were disappointing.
Albert Einstein College of Medicine Receives $4.2 Million NIH Grant to Discover Novel Markers of Early Alzheimer's Disease
Diagnosing Alzheimer's disease can be a complex and time-consuming process, requiring evaluations ranging from brain scans to cognitive and lab tests to reviews of medical history and symptoms.
Genetic varations within the human genome is littered with breadcrumbs leading right up to new therapeutic possibilities.
Typical metabolic syndrome treatment includes a healthy diet, exercise, and possibly metformin, but soon, there may be a new treatment. For that and more research news, continue reading.
The National Cancer Institute-designated Albert Einstein Cancer Center has announced the appointment of three faculty members to key leadership positions, reflecting the center's commitment to basic science, translational, and clinical research and its core principles of diversity, equity, and inclusion.
3/29/2022New research investigates the role chaperone-mediated autophagy (CMA) can play in preventing atherosclerosis, a thickening or hardening of the arteries.
Researchers at Albert Einstein College of Medicine have cleverly developed a vaccine for pancreatic cancer by using the adaptive immunity already present in nearly all of the global population.
Armed with a novel strategy they developed for bolstering the body's immune response, scientists at Albert Einstein College of Medicine have successfully suppressed HIV infections in mice—offering a path to a functional cure for HIV and other chronic viral infections.
Orange Grove Bio, AlleyCorp and Alexandria Venture Investments Establish Partnership with Albert Einstein College of Medicine to Support Development of Novel Therapeutics
Orange Grove Bio, AlleyCorp and Alexandria Venture Investments, three industry leaders dedicated to the acceleration and growth of innovative healthcare and life science companies, announced the formation of a partnership program with Albert Einstein College of Medicine to support the development of novel therapeutics.
Albert Einstein College of Medicine Receives $4 Million NIH Grant To Support Diabetes Prevention and Management Research
Albert Einstein College of Medicine has received a five-year, $4 million grant from the National Institutes of Health to support the New York Regional Center for Diabetes Translation Research.
Albert Einstein College of Medicine Awarded $5 Million for Research on Intellectual and Developmental Disabilities
Albert Einstein College of Medicine has received a five-year, $5 million grant from the National Institutes of Health to support the Rose F. Kennedy Intellectual and Developmental Disabilities Research Center, which has been at the forefront of research on normal and abnormal brain development for more than 50 years.
Albert Einstein College of Medicine and City University of New York Researchers Receive $14.5 Million NIH Grant to Lead HIV Studies in Central Africa
Researchers at Albert Einstein College of Medicine and the City University of New York Graduate School of Public Health and Health Policy (CUNY SPH) have been awarded a five-year, $14.5 million grant from the National Institutes of Health (NIH)
Albert Einstein Cancer Center, Albert Einstein College of Medicine, and Montefiore Health System announced that Lauren Hackett, M.P.A., has been appointed the deputy director of administration of AECC and associate vice president of cancer medicine at Montefiore Medicine.
Most people with cancer who are infected by the novel coronavirus produce antibodies at a rate comparable to the rest of the population—but their ability to do so depends on their type of cancer and the treatments they've received, according to a new study by researchers at Montefiore Health System and Albert Einstein College of Medicine.
Dr. Ari Berman and Dr. Philip Ozuah signed a new agreement between Yeshiva University and Montefiore Medicine launching a joint Yeshiva University -Albert Einstein College of Medicine B.A./B.S.-M.D. program for highly qualified high school graduates ensuring their path to an excellent medical education and an impactful career in hea
Montefiore and Albert Einstein College of Medicine Researchers Are the First to Show this Link [18-December-2020] BRONX, N.Y. , Dec. 18, 2020 /PRNewswire/ -- People hospitalized with COVID-19 and neurological problems including stroke and confusion, have a higher risk of dying than other COVID-19 patients, according to a study published online today by researchers at
The Majority of Vaccine Trial Participants will be People of Color & Individuals Older Than 65
Research led by investigators at the Children's Hospital at Montefiore, Albert Einstein College of Medicine and Yale School of Medicine, identifies symptoms that can predict how severely children will be affected by COVID-19.
Joe Verghese, M.B.B.S., M.S., an international leader in aging and cognition research at Albert Einstein College of Medicine and Montefiore Health System, has received two grants from the National Institutes of Health totaling $13.8 million to conduct studies on pre-dementia and Alzheimer's disease.
Study Finds No Racial Disparity in COVID-19 Case Fatality Rates at Montefiore, When Controlling for Key Risk Factors
Research by Montefiore and Albert Einstein College of Medicine found that Black and Hispanic patients had a higher occurrence of pre-existing conditions and higher rates of hospitalization